𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum acute phase reactants and prognosis in renal cell carcinoma

✍ Scribed by Börje Ljungberg; Kjell Grankvist; Torgny Rasmuson

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
430 KB
Volume
76
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor-associated trypsin inhibitor in no
Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients
✍ Annukka Lukkonen; Susanna Lintula; Kristina von Boguslawski; Olli Carpén; Börje 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 415 KB 👁 2 views

Tumor-associated trypsin inhibitor (TATI) is a 6-kDa peptide, which is identical to the pancreatic-secretory-trypsin inhibitor (PSTI). TATI is produced by several tumors and cancer cell lines, and is used as a serum marker for mucinous ovarian cancer. Elevated serum levels of TATI have also been obs

DNA content and prognosis in renal cell
DNA content and prognosis in renal cell carcinoma. A comparison between primary tumors and metastases
✍ Börje Ljungberg; Roger Stenling; Göran Roos 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 2 views

Deoxyribonucleic acid (DNA) content was retrospectively determined by single-cell cytophotometry in primary tumors and corresponding metastases from 32 patients with renal cell carcinoma. In 15 of the primary tumors a diploid/near diploid and in 17 an aneuploid DNA content was found. A diploid/near